ABAndrew Brett

Andrew Brett

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Andrew Brett has a total of 18 co-authors. Here are the top co-authors by number of shared publications:

  • Anand Murugasu

    Department of Gastroenterology, The Royal Melbourne Hospital City Campus, Parkville, Victoria, Australia

    1 shared publication
  • Angela Zhu

    Department of Gastroenterology and Hepatology Alfred Health Melbourne Victoria Australia

    1 shared publication
  • Belinda Liu

    Department of Respiratory Medicine and Sleep Disorders, Royal Melbourne Hospital, Parkville, Victoria, Australia

    1 shared publication
  • Charlotte A. Slade

    Immunology Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Australia

    1 shared publication
  • Daniel Ng

    Department of Gastroenterology, The Royal Melbourne Hospital, Melbourne, Australia

    1 shared publication
  • Douglas Peter Tjandra

    Department of Gastroenterology, The Royal Melbourne Hospital City Campus, Parkville, Victoria, Australia

    1 shared publication

Latest Publications

  • Open Access

    Gastrointestinal Manifestation of Light Chain Deposition Disease: Beware of the Snakeskin Duodenum

    by Angela Zhu, Jingyi Cheng, James Fiori, Rajiv Kurup, Daniel Ng, Faris Gondal, Andrew Brett

    Gastrointestinal manifestations of light chain deposition disease are exceedingly rare and are characterized by gastrointestinal bleeding, nutritional deficiencies and protein-losing enteropathy. Diagnosis is challenging due to nonspecific symptomatology and indolent disease progression. We describe the case of a 69-year-old woman presenting with melena, chronic diarrhea, and recurrent sepsis. Gastroscopy revealed a highly unusual snakeskin appearance of the duodenum, with histopathology and immunofluorescence confirming light chain deposition disease. This case highlights the importance of prompt biopsy acquisition, hematological evaluation and assessment of extragastrointestinal involvement in facilitating a timely diagnosis, particularly when an underlying lymphoplasmacytic lymphoma is a possible driver of disease.

  • Open Access

    A dominant-negative IFNGR1 variant reveals broad immune cell sequestering of IFN-γ

    by Samantha Chan, Mai B. Margetts, Longfei Wang, Jack Godsell, Josh Chatelier, Belinda Liu, Charlotte A. Slade, Andrew Brett, Kasha P. Singh, Vanessa L. Bryant, et al.

    A dominant-negative IFNGR1 variant reveals broad immune cell sequestering of IFN-γ


  • Use of bevacizumab in a patient with Whipple’s disease: managing diagnostic uncertainty

    by Douglas Peter Tjandra, Andrew Brett, Anand Murugasu

    A man in his 30s with intellectual disability presented with 1 month of diarrhoea, weight loss and dyspnoea. Investigations were hampered due to significant anxiety. Laboratory tests detected microcytic anaemia and hypoalbuminaemia. CT demonstrated a fat-containing infiltrate in the mediastinum, mesentery and axillae, and pulmonary ground-glass infiltrates. Biopsy of the axilla showed cystic lymphatic malformations involving adipose tissue and lymph nodes, leading to a provisional diagnosis of generalised lymphatic anomaly. Over the subsequent 4 months, the patient’s respiratory status deteriorated, leading to type 1 respiratory failure necessitating intubation. After multidisciplinary discussion, a decision was made to trial bevacizumab, an anti-VEGF agent, with subsequent improvement in respiratory status. While intubated, gastroscopy was performed; duodenal biopsies revealed pathognomonic changes of Whipple’s disease, confirmed on PCR of duodenal and axillae biopsies. This was deemed the most likely unifying diagnosis; antibiotic treatment was commenced, bevacizumab was ceased, and the patient has remained well after 18 months.